VivoSeq
Other

Breast

1

Pipeline Programs↗

15

Active Trials↗

9

Companies Involved↗

Breast is an early-stage landscape with 1 program across 9 companies. The most active players are AstraZeneca, Pfizer, Pacira Pharmaceuticals, Inc.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

27/100

Mech. Concentration

100/100

Completion Rate

91/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

AstraZeneca logo

AstraZeneca

1 program

Phase 2Pfizer logo

Pfizer

0 programs

PreclinicalPacira Pharmaceuticals, Inc logo

Pacira Pharmaceuticals, Inc

0 programs

PreclinicalA

Ascendis Pharma A/S

0 programs

PreclinicalIdorsia Pharmaceuticals Ltd. logo

Idorsia Pharmaceuticals Ltd.

0 programs

PreclinicalSupernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 21

Olaparib

AstraZeneca

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

53

clinical trials

Completed31 · 58%
Recruiting6 · 11%
Not yet recruiting4 · 8%
Unknown status4 · 8%
Active, not recruiting4 · 8%
Withdrawn2 · 4%
Other2 · 4%

Clinical Trials

Trial Activity

53 trials

Cannabidiol Into Breastmilk
Recruiting·—·N/A·NCT06589258·60 enrolled
Medicines in Breast Milk and Estimated Infant Exposure
Recruiting·UUniversity Hospital Bispebjerg and Frederiksberg·N/A·NCT07346716·250 enrolled
Feasibility and Safety of Intranasally Administered Breast Milk in HIE
Recruiting·SSemmelweis University·Phase 1·NCT06747260·10 enrolled
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
Recruiting·UUNC Lineberger Comprehensive Cancer Center·Phase 1·NCT05754749·20 enrolled
Role of TXA in Patients Undergoing Breast Free Flap Reconstruction
Recruiting·UUniversity of Virginia·Phase 4·NCT06428682·100 enrolled
Intranasal Breast Milk Therapy in HIE
Recruiting·SSemmelweis University·Phase 1·NCT06746532·80 enrolled
RANKL Inhibition and Mammographic Breast Density
Active, not recruiting·WWashington University School of Medicine·Phase 2·NCT04067726·210 enrolled
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Active, not recruiting·ECOG-ACRIN Cancer Research Group·Phase 3·NCT03233191·108,508 enrolled
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer
Active, not recruiting·National Cancer Institute (NCI)·Phase 2·NCT03598257·300 enrolled
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
Active, not recruiting·HHologic, Inc.·Preclinical·NCT06636539·75 enrolled
A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Not yet recruiting·AAscendis Pharma A/S·N/A·NCT07264634·10 enrolled
Postpartum 8-aminoquinoline Breast Milk Study
Not yet recruiting·—·Phase 2/3·NCT07060404·60 enrolled
Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution
Not yet recruiting·SStanford University·Phase 1·NCT04016818·20 enrolled
Feasibility of Imaging Breast Implants With a Transmission-based Transmission Scanner
Not yet recruiting·UUniversity of Calgary·Preclinical·NCT07487792·10 enrolled
Feasibility of Comparing Microwave Images to Clinical Information in Patients Recalled for Follow-up Breast Imaging
Enrolling by invitation·UUniversity of Calgary·Preclinical·NCT07273565·100 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)